证券记录 · 已归档季度
BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
14被追踪持有人
—Δ持有人
30.72M持有股份
$7.12B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 161 | 0 | 119.37M | $25.77B | +6 | −5 |
| Q1 2026 | 163 | -1 | 110.78M | $20.30B | +4 | −6 |
| Q4 2025 | 163 | 0 | 123.15M | $21.67B | +2 | −1 |
| Q3 2025 | 24 | +1 | 81.72M | $11.44B | +1 | −1 |
| Q2 2025 | 21 | 0 | 78.50M | $9.86B | — | — |
| Q1 2025 | 18 | +2 | 41.87M | $5.73B | +3 | −1 |
| Q4 2024 | 16 | -1 | 41.64M | $6.37B | — | −1 |
| Q3 2024 | 16 | +2 | 32.39M | $6.28B | +2 | — |
| Q2 2024 | 14 | — | 30.72M | $7.12B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 16.34M | — | $3.79B | 2.7% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.17M | — | $1.20B | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 3.57M | — | $824.55M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 3.57M | — | $824.55M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 2.08M | — | $481.89M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 2.01M | — | $466.29M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 2.01M | — | $466.29M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 618.11K | — | $143.29M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 239.85K | — | $55.60M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 214.69K | — | $49.77M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 212.90K | — | $49.35M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 137.70K | — | $31.92M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 68.49K | — | $15.88M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 23.56K | — | $5.46M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 23.56K | — | $5.46M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 23.56K | — | $5.46M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 16.42K | — | $3.81M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 995 持有人, 132.27M 股份, $23.30B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据